Of note this is where a lot or AVR's staff overhead cuts appear to have occurred when we pivoted from the previous IV/product sales company into a product development company a few years ago. It takes a lot of man/woman power to market and sell to big corporations like hospitals/clinics. At least to practitioners it's individual reps who build the relationships, and it's the practitioners that set the device/tool preference that in turn get supplied to hospitals for procedures, not other management non-clinical heads. This is where being the best device in the business gets us into patients - in most specialties I'd say this is a slow process like orthopaedics where all cements/prosthetics are larger comparable.
I really think we are leaps and bounds beyond the competition and cardiologists are pretty savvy. Though I doubt this will be our problem to worry about. Ramble over
- Forums
- ASX - By Stock
- Ann: DurAVR First In Human Patient 6 Month Study Follow Up
AVR
anteris technologies global corp.
Add to My Watchlist
6.09%
!
$6.27

Of note this is where a lot or AVR's staff overhead cuts...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.27 |
Change
0.360(6.09%) |
Mkt cap ! $97.17M |
Open | High | Low | Value | Volume |
$5.93 | $6.30 | $5.91 | $107.9K | 17.39K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | $6.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.27 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3500 | 6.120 |
1 | 2000 | 6.100 |
1 | 1000 | 6.000 |
1 | 1250 | 5.950 |
1 | 857 | 5.830 |
Price($) | Vol. | No. |
---|---|---|
6.270 | 200 | 1 |
6.300 | 463 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
6.550 | 1092 | 1 |
Last trade - 15.42pm 27/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online